Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore

Annals of the Academy of Medicine Singapore

Volumn 34, Issue 2, 2005, Pages 169-178

  Shah, V A ^a   Yeo, C L ^a   Ling, Y L F ^b   Ho, L Y ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

Author keywords

Chronic lung disease; Follow up; Mechanical ventilation; Pulmonary function

Indexed keywords

OXYGEN;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CHRONIC LUNG DISEASE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MATERNAL DISEASE; NEWBORN; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PREECLAMPSIA; PREMATURITY; RETROLENTAL FIBROPLASIA; RISK FACTOR; SINGAPORE; VERY LOW BIRTH WEIGHT;

EID: 17444395224     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Chang SY, Shu JL, Feng LH, Wen MH, Jorn HL. Retinopathy of prematurity: screening, incidence and risk factors analysis. Chin Med J (Taipei) 2001;64:706-12.
2. Gong A, Anday E, Boros S, Bucciarelli B, David, Zucker; American Exosurf Neonatal Study Group I. One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. J Pediatr 1995;126:S68-S74.
3. Valentine PH, Jackson JC, Kalina RE, Woodrum DE. Increased survival of low birth weight infants: impact on the incidence of retinopathy of prematurity. Pediatrics 1989;84:442-5.
4. Gibson DL, Sheps SB, Uh SH, Schechter MT, McCormick AQ. Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics 1990;6:405-12.
5. Schalij-Delfos NE, Cats BP. Retinopathy of prematurity: the continuing threat to vision in preterm infants. Acta Ophthalmol Scand 1997;75:72-5.
6. Nissenkorn I, Wijsenbeek Y, Cohen S. Etiology of blindness in children in Israel in recent years. Acta XXV Council Ophthalmol 1987;25:742-4.
7. Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats DK. Childhood blindness. J AAPOS 1999;3:26-32.
8. Goggin M, O'Keefe M. Childhood blindness in the Republic of Ireland; a national survey. Br J Ophthalmol 1991;75:425-49.
9. Fleck BW, Dangata Y. Causes of visual handicap in the Royal Blind School, Edinburgh, 1991-2. Br J Ophthalmol 1994;78:421.
10. Gibson DL, Sheps SB, Schechter MT, Wiggins S, McCormick AQ. Retinopathy of prematurity: a new epidemic? Pediatrics 1989;83:486-92.
11. Saugstad OD. Is oxygen more toxic than currently believed? Pediatrics 2001;108:1-6.
12. 2 variation determines the oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci 1995;2063-70.
13. Lucey JF, Dangman B. A re-examination of oxygen in retrolental fibroplasia. Pediatrics 1984;73:82-96.
14. Cats BP. Retinopathy of prematurity: review of a four-year period. Br J Ophthalmol 1985;500-3.
15. Arroe M, Peitersen B. Retinopathy of prematurity: review of a seven-year period in Danish neonatal intensive care unit. Acta Pediatr 1994;83:501-5.
16. Palmer EA, Flynn JT, Hardy RJ. Incidence and course of retinopathy of prematurity. Ophthalmology 1991;98:1628-40.
17. Tan KE, Cats BP. Why is there an increase in ROP in recent years? Bull Soc Belg Ophthalmol 1991;241:37-40.
18. Keith CG, Doyle LW. Retinopathy of prematurity in extremely low birth weight infants. Pediatrics 1995;95:42-5.
19. Siatskowski RM, Flynn JT. Retinopathy of prematurity. In: Nelson L, editor. Harley's Pediatric Ophthalmology. 4th ed. Philadelphia, PA: WB Saunders Co, 1998.
20. Report of a joint working party. Retinopathy of prematurity: guidelines for screening and treatment. London: Royal College of Ophthalmologist and British Association of Perinatal Medicine, 1995.
21. Goble RR, Jones HS, Fielder AR. Are we screening too many babies for retinopathy? Eye 1997;11:509-14.
22. International Committee. An International classification of retinopathy of prematurity? Br J Ophthalmol 1984;68:690-7.
23. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. An International Classification of Retinopathy of Prematurity. II. The classification of retinal detachment. Arch Ophthalmol 1987;105:906-12.
24. Kitchen WH, Robinson HP, Dickinson AJ. Revised intrauterine growth curves for an Australian hospital population. Aust Paediatr J 1983;19:157-61.
25. Lee J, Rajadurai VS, Tan KW. Blood pressure standards for very low birthweight infants during the first day of life. Arch Dis Child Fetal Neonatal Ed 1999;81:F168-F170.
26. Bell MJ, Ternberg JL, Feigin RD. Neonatal necrotizing enterocolitis. Therapeutic decision based upon clinical staging. Ann Surg 1978;187:1-7.
27. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular haemorrhage: a study of infants with birth weights less than 1,500gm. J Pediatr 1978;92:529-34.
28. Shennan AT, Dunn MS, Ohlsson A. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82:527-32.
29. Clemett R, Darlow B. Results of screening low-birth-weight infants for retinopathy of prematurity. Curr Opin Ophthalmol 1999;10: 155-63.
30. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. I. Preliminary report. Am J Ophthalmol 1942;25:203-6.
31. Darlow BA, Horwood LJ, Clemett RS. Retinopathy of prematurity: risk factors in a prospective population-based study. Paediatr Perinat Epidemiol 1992;6:62-80.
32. Maheshwari R, Kumar H, Paul VK, Singh M, Deorari AK, Tiwari HK. Incidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi, 1996. Natl Med J India 1996;9:211-4.
33. Haugen OH, Markestad T. Incidence of retinopathy of prematurity (ROP) in the western part of Norway. A population-based retrospective study. Acta Ophthalmol Scand 1997;75:305-7.
34. Bassiouny MR. Risk factors associated with retinopathy of prematurity: a study from Oman. J Trop Pediatr 1996;42:355-8.
35. Lappi M. Retinopathy of prematurity in southern Finland, Acta Ophthalmol Suppl 1993;210:56-8.
36. Smith J, Spurrier N, Goggin M. Retinopathy of prematurity in South Australian neonatal intensive care unit. Aust N Z Ophthalmol 1995;23:49-54.
37. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics 1999;104:26-41.
38. Shastry BS, Pendergrast SD, Hatzer MK, Liu X, Trese MT. Identification of missense mutation in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 1997;115:651-5.
39. Ng YK, Fielder AR, Shaw DE, Levene MI. Epidemiology of retinopathy of prematurity. Lancet 1988;2:1235-8.
40. Charles JB, Ganthier R, Appiah AP. Incidence and characteristics of retinopathy of prematurity in a low-income inner city population. Ophthalmology 1991;98:14-7.
41. Rowlands E, Ionided AC, Chinn S, Mackinnon H, Darvey CC. Reduced incidence of retinopathy of prematurity. Br J Ophthalmol 2001;85:933-5.
42. Fledelius HC. Retinopathy of prematurity in a Danish county. Trends over the 12-year period 1982-93. Acta Ophthalmol Scand 1996;74:285-7.
43. Fledelius HC, Dahl H. Retinopathy of prematurity, a decrease in frequency and severity. Trends over 16 years in a Danish county. Acta Ophthalmol Scand 2000;78:359-66.
44. Vyas J, Field D, Draper ES, Woodruff G, Fielder AR, Thompson J. Severe retinopathy of prematurity and its association with different rates of survival in infants less than 1251g birth weight. Arch Dis Child Fetal Neonatal Ed 2000;82:F145-9.
45. Bardin C, Rossignol M, Papageorgiou A. Retinopathy of prematurity and intrauterine growth retardation in infants <1000 g. Pediatr Res 1995;37:249.
46. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988;106:471-9.
47. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: three-month outcome. Arch Ophthalmol 1990; 108:195-201.
48. Palmer EA. Optimal timing of examination for acute retrolental fibroplasia. Ophthalmology 1981;88:662-8.
49. American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Ophthalmology. Screening examination of premature infants for retinopathy prematurity. Ophthalmology 1997;104:888-9.
50. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB; Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology 1991;98:1628-40.
51. Higgins RD, Mendelson AL, DeFeo MJ, Ucsel R, Hendricks M. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol 1998;116:601-5.
52. Reisner SH, Amir J, Shohant M, Krikler R, Nissenkorn I, Ben-Sira I. Retinopathy of prematurity: incidence and treatment. Arch Dis Child 1985;60:698-701.
53. Bullard SR, Donahue SP, Feman SS, Sinatra RB, Walsh WF. The decreasing incidence and severity of retinopathy of prematurity. J AAPOS 1999;3:46-52.
54. Reynolds JD. Incidence and severity of retinopathy of prematurity. J AAPOS 1999;3:321-2.
55. Reynolds JD, Hardy RJ, Kennedy KA, Spencer R, Van Heuven WAJ, Fielder AR. Light reduction in retinopathy of prematurity (LIGHT-ROP) Cooperative group. Lack of efficacy of light reduction in preventing retinopathy of prematurity. N Engl J Med 1998;338:1572-6.
56. Blair BM, O'halloran HS, Pauly TH, Stevens JL. Decreased incidence of retinopathy of prematurity, 1995-1997. J AAPOS 2110;5:118-22.
57. Patz A, Hoeck LE, De La Cruz E. Studies on the effect of oxygen administration in retrolental fibroplasia: I, nursery observations. Am J Ophthalmol 1952;35;1248-53.
58. Shohat M, Reisner SH, Krikler R, Nissenkorn I, Yassur Y, Ben-Sira I. Retinopathy of prematurity: incidence and risk factors. Pediatrics 1983;72:159-63.
59. Smith LM, Qureshi N, Chao CR. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation. J Matern Fetal Med 2000;9:131-5.
60. Cuculich PS, DeLozier KA, Mellen BG, Shenai JP. Postnatal dexamethasone treatment and retinopathy of prematurity in very low birthweight neonates. Biol Neonate 2001;79:9-14.
61. Mizoguchi MB. Dopamine use is an indicator for the development of threshold retinopathy of prematurity? Br J Ophthalmol 1999;83:425-8.
62. Chye JK, Lim CT, Leong HL, Wong PK. Retinopathy of prematurity in very-low-birth-weight infants. Ann Acad Singapore 1999;28:193-8.
63. Withagen MI. Neonatal outcome of temporizing treatment in early-onset preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001;94:211-5.